Dublin, January 4, 2023 /PRNewswire/ — Added Renal Biomarkers: Technology and Global Market report of ResearchAndMarkets.com Recruitment.
This report incorporates an in-depth analysis of the renal biomarkers market including market forecasts and trends to 2021.
It details key players, competitive information, innovative technologies, market dynamics and regional opportunities. The report examines recent developments and product portfolios of key players. Patent analysis focuses on recent technology trends in regions such as the United States. EuropeWhen JapanThe report presents market analysis and estimates the CAGR of renal biomarkers.
The kidney biomarker market is growing at a steady pace due to the increasing prevalence and incidence of two major kidney diseases, acute kidney injury (AKI) and chronic kidney disease (CKD). These illnesses increase hospital stays, leading to higher costs and morbidity. Early detection of such diseases will lead to better treatments enabled by biomarkers.
COVID-19 has had a major impact on the increased incidence of kidney disease. Long-term her COVID patients have a higher incidence of AKI or CKD. Lifestyle-related diseases such as diabetes and hypertension are also on the rise. These are closely associated with renal damage and dysfunction. These diseases are currently the 16th leading cause of death, but are expected to become the 5th leading cause by 2030.
Conventional biomarkers used to detect AKI and CKD have many drawbacks compared to newer biomarkers. New biomarkers are being researched and discovered as there are gaps in the ideal renal biomarker. There is no single renal tumor biomarker that the industry can pursue.
The scope of the report applies only to renal biomarker consumables and not to devices used for renal biomarker research. All types of renal biomarkers have been considered for research, clinical trials, and diagnostic purposes.
This report categorizes the global market by these regions. North America, Europe, Asia Pacific, and Rest of the World (RoW) regions. For market forecasts, data are provided using 2021 as a base year, and forecasts are provided for 2022 and the end of 2027.
What is included in the report
-
Analysis of global market trends, including 2019-2021 market revenue data, 2022 estimates, and compound annual growth rate (CAGR) forecasts to 2027
-
Estimation of actual market size and revenue forecast of the renal biomarkers market and corresponding market share analysis by assay type, application, end user and region
-
Update on Renal Biomarkers Market Drivers and Opportunities, Key Changes, Regulatory and Industry-Specific Challenges, and Other Demographic Factors Shaping Market Demand in the Years to Come (2022-2027)
-
Identify companies best positioned to meet demand through unique technologies, product launches, mergers and acquisitions, and other market strategic advantages
-
Review of recent biomarker industry structure, research and development activities, and analysis of competitive landscape based on recent developments and segment revenue
-
Biomarker and related technology patent activity and patent grant review
-
Easy-to-follow company profiles of market-leading players such as BioMerieux, Gentian Diagnostic, Proteomics International, Thermo Fisher Scientific, SphingoTec and BioPorto
Main topics:
Chapter 1; Introduction
Chapter 2. Summary and Highlights
Chapter 3 Market Overview
3.1 Introduction
3.1.1 Kidney
3.1.2 Renal biomarkers
3.1.3 Definitions
3.2 Market dynamics
3.2.1 Driver
3.2.2 Constraints
3.2.3 Opportunities
3.3 Biomarker regulatory process
3.3.1 European Medicines Agency
3.3.2 Biomarkers recognized by FDA
Chapter 4 Impact of the Covid-19 Pandemic
4.1 Impact of Covid-19 on Renal Biomarker Market
4.1.1 Increased incidence of Aki
4.1.2 Other diseases
4.2 Chronic dialysis patients
4.2.1 Renal transplant recipient
Chapter 5 Global Renal Biomarkers Market by Type
5.1 Overview
5.2 Filtered renal biomarkers (tubular reabsorption)
5.2.1 Albumin
5.2.2 Cystatin C
5.2.3 Beta-2 microglobulin
5.3 Upregulated biomarkers
5.3.1 Kim-1 Kidney Injury Molecule
5.3.2 Neutrophil gelatinase-associated lipocalins
5.3.3 Cluster
5.3.4 Interleukin-18
5.3.5 Netrin-1
5.4 Preform
5.4.1 Alkaline phosphatase
5.4.2 γ-glutamyltranspeptidase
5.4.3 Glutathione S-transferase
5.4.4 N-acetyl-bD glucosaminidase
5.4.5 Liver-type fatty acid-binding protein
5.4.6 Tissue inhibitors of metalloproteinase 2 and insulin-like growth factor binding protein 7
5.5 Other biomarkers
5.5.1 Blood urea nitrogen
5.5.2 Serum creatinine
5.5.3 Down-regulation
Chapter 6 Global Market for Kidney Biomarkers by Region
6.1 North America
6.1.1 America
6.1.2 Canada
6.2 Europe
6.2.1 Germany
6.2.2 Italy
6.2.3 France
6.2.4 Spain
6.2.5 England
6.2.6 Rest Europe
6.3 Asia Pacific
6.3.1 Australia
6.3.2 Japan
6.3.3 China
6.3.4 Rest Asia
6.4 Other countries
Chapter 7 Renal Biomarkers Market by End-Users
7.1 Hospital
7.2 Research Center
7.3 Other End Users
8. Renal Biomarker Market by Technology
8.1 Overview
8.2 Enzyme-linked immunosorbent assay
8.3 Particle-enhanced turbidity immunoassay
8.4 Colorimetric Assay
8.5 Chemiluminescent Enzyme Immunoassay
8.6 Other detection methods
Chapter 9 Competitive Environment
Chapter 10 Company Profile
Chapter 11 Patent Examination
Chapter 12 Clinical Trial Analysis
For more information on this report, please visit https://www.researchandmarkets.com/r/ranp91.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.
Media contact:
research and market
Laura WoodSenior Manager
press@researchandmarkets.com
For EST office hours, please call +1-917-300-0470.
US/Canada Toll Free +1-800-526-8630
For GMT office hours, please call +353-1-416-8900.
US Fax: 646-607-1904
Fax (outside US): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View Original Content: https://www.prnewswire.com/news-releases/renal-biomarkers-technologies-and-global-report-2022-market-data-and-projections-2019-2027-featuring-biomerieux- gentian-diagnostics-proteomics-thermo-fisher-scientific-sphingotec-and-bioporto-301713427.html
SOURCE Research and Market
